{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:48:21Z","timestamp":1789202901603,"version":"build-2803163510"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230670-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The prescribing of stimulant medications for attention-deficit\/hyperactivity disorder (ADHD) has increased in the US. Prescription stimulants are one of the most commonly misused controlled substances during adolescence. Despite a 10-fold increase in stimulant-related overdose deaths in the past decade, the transitions from prescription stimulants to illicit stimulants (eg, cocaine, methamphetamine) remain relatively unknown in longitudinal population-based studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the longitudinal transitions from adolescents\u2019 prescription stimulant exposure (ie, stimulant therapy for ADHD and prescription stimulant misuse [PSM]) to later cocaine and methamphetamine use during young adulthood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>National longitudinal multicohort panels of US 12th grade public and private school students in the coterminous US were assessed annually (baseline cohort years 2005-2017 [between March and June]) and followed up across 3 waves over a 6-year period to 23 to 24 years of age (follow-up years 2011-2021 [between April and October]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>History of self-reported stimulant therapy for ADHD at baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incidence and prevalence of past-year use of cocaine and methamphetamine during young adulthood (19-24 years of age).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 5034 students enrolled at baseline (2589 [52.0%] female), 470 (10.2% [95% CI,\u20099.4%-11.2%]) reported use of stimulant therapy for ADHD, 671 (14.6% [95% CI,\u200913.5%-15.6%]) reported PSM only, and 3459 (75.2% [95% CI,\u200973.9%-76.4%]) reported neither (and served as population controls). In controlled analyses, there were no statistically significant differences between adolescents who reported stimulant therapy for ADHD at baseline compared with population controls in the adjusted odds of transitioning to later cocaine or methamphetamine initiation or use during young adulthood (19-24 years of age). In contrast, PSM during adolescence in those not treated with stimulants for ADHD had significantly higher odds of transitioning to later cocaine or methamphetamine initiation and use during young adulthood compared with population controls (adjusted odds ratio,\u20092.64 [95% CI,\u20091.54-4.55]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230670-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this multicohort study, adolescents\u2019 stimulant therapy for ADHD was not associated with increased risk of later cocaine and methamphetamine use during young adulthood. Adolescents\u2019 prescription stimulant misuse offered a signal for subsequent cocaine or methamphetamine use and warrants monitoring and screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.22650","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:00:39Z","timestamp":1689073239000},"page":"e2322650","source":"Crossref","is-referenced-by-count":23,"title":["Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit\/Hyperactivity Disorder During Adolescence"],"prefix":"10.1001","volume":"6","author":[{"given":"Sean Esteban","family":"McCabe","sequence":"first","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor"},{"name":"Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Schulenberg","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Department of Psychology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Wilens","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Department of Psychiatry, Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty S.","family":"Schepis","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Department of Psychology, Texas State University, San Marcos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita V.","family":"McCabe","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil T.","family":"Veliz","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor"},{"name":"Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"zoi230670r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108297","article-title":"Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty\u2014United States, 2014-2019.","volume":"217","author":"Board","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"zoi230670r2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.15585\/mmwr.mm7213a1","article-title":"Trends in stimulant prescription fills among commercially insured children and adults\u2014United States, 2016\u20132021.","volume":"72","author":"Danielson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi230670r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1471","article-title":"Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016.","volume":"1","author":"Xu","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi230670r4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1176\/appi.ajp.2008.08020237","article-title":"Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?","volume":"165","author":"Volkow","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"12","key":"zoi230670r8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults.","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2-3","key":"zoi230670r9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.drugalcdep.2006.12.020","article-title":"Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.","volume":"89","author":"Wu","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi230670r11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":"Statistical analysis of correlated data using generalized estimating equations: an orientation.","volume":"157","author":"Hanley","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi230670r12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach.","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"},{"issue":"3","key":"zoi230670r13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11920-013-0436-6","article-title":"The complicated relationship between attention deficit\/hyperactivity disorder and substance use disorders.","volume":"16","author":"Zulauf","year":"2014","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"zoi230670r14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaac.2019.06.012","article-title":"Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies.","volume":"59","author":"Faraone","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"22","key":"zoi230670r15","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.8020","article-title":"Screening for unhealthy drug use: US Preventive Services Task Force Recommendation Statement.","volume":"323","author":"Krist","year":"2020","journal-title":"JAMA"},{"key":"zoi230670r5","volume-title":"College Students & Adults Ages 19-60","author":"Schulenberg","year":"2021"},{"key":"zoi230670r6","volume-title":"Secondary school students","author":"Miech","year":"2021"},{"key":"zoi230670r7","unstructured":"Ahmad? FB, Rossen? LM, Sutton? P. Provisional drug overdose death counts. National Center for Health Statistics. Reviewed May 17, 2023. Accessed September 10, 2021. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi230670r10","unstructured":"StataCorp LLC. Stata Statistical Software: Release 17. StataCorp LLC. Accessed October 25, 2022. https:\/\/www.stata.com\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2807139\/mccabe_2023_oi_230670_1688156417.32373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:00:45Z","timestamp":1689073245000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2807139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.22650","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]}}}